[ASND] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
02-Apr-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- -67.58%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 51,174 7,778 6,953 13,375 10,581 1,530 4,606 49.35%
PBT -577,817 -383,944 -419,174 -218,250 -130,491 -124,374 -68,732 42.57%
Tax 5,377 -367 -219 -234 -394 -477 -227 -
NP -583,194 -383,577 -418,955 -218,016 -130,097 -123,897 -68,505 42.87%
Tax Rate - - - - - - - -
Total Cost 634,368 391,355 425,908 231,391 140,678 125,427 73,111 43.32%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -1,139.63 -4,931.56 -6,025.53 -1,630.03 -1,229.53 -8,097.84 -1,487.30 -4.33%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -10.40 -7.00 -8.28 -4.69 -3.17 -3.68 -2.58 26.14%
EPS Diluted -10.40 -7.00 -8.28 -4.69 -3.17 -3.68 -2.58 26.14%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.